Netoglitazone

NS-102 is a selective kainate (GluK2) receptor antagonist. NS-102 is a potent GluR6/7 receptor antagonist .In VitroCombination of NS-102 (10 μM) and GYKI 52466 (30 μM) preventes full loss of compound action potentials (CAPs) during oxygen and

NS-102 is a selective kainate (GluK2) receptor antagonist. NS-102 is a potent GluR6/7 receptor antagonist .In VitroCombination of NS-102 (10 μM) and GYKI 52466 (30 μM) preventes full loss of compound action potentials (CAPs) during oxygen and

NS-102 is a selective kainate (GluK2) receptor antagonist. NS-102 is a potent GluR6/7 receptor antagonist .In VitroCombination of NS-102 (10 μM) and GYKI 52466 (30 μM) preventes full loss of compound action potentials (CAPs) during oxygen and

An FGF inhibitor.

An FGF inhibitor.

An FGF inhibitor.

Wnt signaling inhibitor: binds the PDZ domain of the Dishevelled (Dvl) protein.

Wnt signaling inhibitor: binds the PDZ domain of the Dishevelled (Dvl) protein.

An analog of scriptaid that lacks scriptaid&rsquos HDAC inhibitory effects used as a negative control in experiments involving scriptaid.

O-Desmethyl Gefitinib is a major metabolite of Gefitinib, which is a potent inhibitor of tyrosine residue phosphorylation in EGFR.

O8 OGG1 Inhibitor.

OC000459 is a potent and selective D prostanoid receptor 2 (DP2) antagonist with IC50 of 13 nM.